Skip to main navigation
Overview
Newsroom
News Releases
Corporate Statements
Multimedia Resources
Events & Presentations
Events
Presentations
Financials
SEC Filings
Annual Reports
Stock Information
Stock Quote & Chart
Analyst Coverage
Investor FAQs
Corporate Governance
Governance Documents
Committee Composition
Leadership
Code of Business Conduct
Corporate Responsibility
Contact the Board
Top bar
Biogen.com
Information Request
Sign up for Alerts
Search
Search
Search
SEC Filings
Form 4
SEC Filings
Form 4
SEC Filings
Form 4
SEC Filings
Form 4
SEC Filings
Form 3
SEC Filings
Form 3
News
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Ranibizumab Biosimilar, BYOOVIZ™
News
EISAI and Biogen Inc. Announce U.S. FDA Grants Breakthrough Therapy Designation for LECANEMAB (BAN2401), an Anti-Amyloid Beta Protofibril Antibody for the Treatment of Alzheimer's Disease
News
Biogen and Eisai Update for the Alzheimer’s Disease Community
News
Biogen to Participate in SVB Leerink’s 3rd Annual CNS Forum
Pagination
Previous page
‹‹
Page 3
Next page
››
Filter by gallery
No facets
Your selection
None
Filter by category
Filter by category
Filter by category
Filter by category
Filter by type
Filter by tags
Filter by form group
Filter by content year
2021
(155)
2020
(148)
2019
(138)
2018
(147)
2017
(143)
2016
(164)
2015
(173)
2014
(161)
2013
(172)
2012
(162)
2011
(178)
2010
(168)
2009
(204)
2008
(239)
2007
(156)
2006
(132)
2005
(114)
2004
(179)
2003
(97)
2002
(21)
2001
(15)
2000
(22)
1999
(22)
1998
(19)
1997
(21)
1996
(19)
Filter by content type
SEC filing
(2244)
News
(815)
Asset
(98)
Person
(47)
Event
(34)
Landing page
(21)
Governance committee
(3)
Tools
Print Page
Stockholder Communications
E-mail Alerts
FAQs
Facebook
Twitter
LinkedIn
Google+
